Vectura Group Ltd.
Overview
Vectura Group Ltd. is a UK-based pharmaceutical company specializing in inhalation products. It became a subsidiary of Philip Morris International in 2021 and focuses on developing therapies primarily for respiratory conditions.
Therapeutic areas
RespiratoryInhalation therapies
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Vectura Group Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
AstraZeneca AB
United Kingdom
AstraZeneca PLC
United Kingdom
GlaxoSmithKline plc
United Kingdom
GlaxoSmithKline plc and Vir Biotechnology, Inc.
United Kingdom
GSK Contract Manufacturing
United Kingdom
Hikma Pharmaceuticals PLC
United Kingdom
Quotient Sciences Ltd.
United Kingdom
Skyepharma Production S.A.S.
United Kingdom
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.